The OCTARAY™ Mapping Catheter enables shorter mapping times, faster acquisition rates, and provides better clarity in high-density maps to improve procedural efficiency.

Biosense Webster, Inc. radiofrequency ablation technology enables efficient, effective, and safe atrial fibrillation ablations at a lower cost as compared to cryoablation.

ICE guided LAAO procedures help to reduce procedure time, fluoroscopy time, and healthcare utilization, therefore providing procedural benefits and cost-savings.

Improved visualization with the CARTO VIZIGO^® Sheath optimizes catheter stability and navigation in order to improve procedure safety and efficiency.

The VISITAG SURPOINT™ Module utilizes Biosense Webster, Inc. technology to increase the effectiveness, efficiency, and reproducibility of ablation procedures for paroxysmal atrial fibrillation.

Use of intracardiac echocardiography (ultrasound) during ablation procedures improves procedural efficiency and reduces fluoroscopy need.

Biosense Webster, Inc. technology reduces overall procedure time thereby improving efficiency and enabling you to treat more patients.

The use of Biosense Webster, Inc. technology helps minimize radiation exposure by reducing fluoroscopy time during atrial fibrillation ablation.

Earlier restoration of sinus rhythm in atrial fibrillation patients may reduce disease progression, improve long-term procedural success, and lower overall patient mortality.

Having an efficient ER AFib pathway to streamline AFib care can reduce diagnosis to ablation time, hospitalizations, and healthcare utilization among patients.